The p.Pro482Ala Variant in the CNNM2 Gene Causes Severe Hypomagnesemia Amenable to Treatment with Spironolactone

Int J Mol Sci. 2022 Jun 30;23(13):7284. doi: 10.3390/ijms23137284.

Abstract

Renal hypomagnesemia syndromes involving CNNM2 protein pathogenic variants are associated with variable degrees of neurocognitive dysfunction and hypomagnesemia. Here, we report a family with a novel CNNM2 p.Pro482Ala variant, presenting with overt hypomagnesemia and mild neurological involvement (autosomal dominant renal hypomagnesemia 6, HOMG6, MIM# 613882). Using a bioinformatics approach, we showed that the p.Pro482Ala amino acid substitution causes a 3D conformational change in CNNM2 structure in the cystathionin beta synthase (CBS) domain and the carboxy-terminal protein segment. A novel finding was that aldosterone inhibition with spironolactone helped to alleviate hypomagnesemia and symptoms in the proband.

Keywords: CNNM2; HOMG6; hypomagnesemia; whole exome sequencing.

MeSH terms

  • Amino Acid Substitution
  • Cation Transport Proteins* / metabolism
  • Kidney / metabolism
  • Magnesium / metabolism
  • Spironolactone* / therapeutic use

Substances

  • Cation Transport Proteins
  • Spironolactone
  • Magnesium

Grants and funding

This work was supported by the charity EMEKNNOK KIDS-CRETE (Kidney Inherited Diseases reSearch in Crete), VAT 996845022, Kalessa Heraklion 71500, Greece.